Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis

OBJECTIVES: To evaluate the clinical curative effects and toxicity of recombinant human adenovirus-p53 injection (rAd-p53) plus chemotherapy (CT), radiotherapy (RT), or concurrent chemoradiotherapy (CRT) for the treatment of cervical cancer. METHODS: We identified 14 eligible studies in the PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yaru, Chen, Jiuzhou, Zhang, Xiwen, Fang, Miao, Xu, Mingna, Zhang, Longzhen, Rao, Enyu, Xin, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558497/
https://www.ncbi.nlm.nih.gov/pubmed/34733786
http://dx.doi.org/10.3389/fonc.2021.748681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558497/
https://www.ncbi.nlm.nih.gov/pubmed/34733786
http://dx.doi.org/10.3389/fonc.2021.748681

Ejemplares similares